Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the month of March 2022, with a specific reporting date of March 11, 2022. The document serves as a transaction notification regarding the acquisition of ordinary shares by Persons Discharging Managerial Responsibilities (PDMRs) and Persons Closely Associated (PCAs) under the Company's Share Reward Plan.
Key Financial Metrics
The filing does not provide consolidated financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. It is strictly a disclosure of insider trading activity.
| Transaction Date | Instrument | Transaction Type | Price per Share | Total Volume |
|---|---|---|---|---|
| 2022-03-09 | Ordinary Shares (25p each) | Acquisition (Share Reward Plan) | £15.3237 | 160 shares (aggregated across 10 individuals) |
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The document details routine share acquisitions by senior executives and their associates, which are standard compliance disclosures rather than indicators of material business changes.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or contingencies. It is a regulatory notification of specific share transactions executed on the London Stock Exchange.
Key Facts for Investor Verification
- Transaction Nature: All reported transactions were acquisitions of ordinary shares under the Company's Share Reward Plan, involving partnership and matching shares.
- Participants: The filing covers 10 individuals, including the CEO (Ms E Walmsley), President of Vaccines (Mr R Connor), and other senior officers.
- Transaction Volume: The total volume reported is minimal (16 shares per individual for most, 18 for one individual), indicating these are likely vesting or matching contributions rather than significant open-market purchases.
- Price Consistency: All transactions occurred at a uniform price of £15.3237 per share on March 9, 2022.